Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Risk Factors Associated with Perinatal Relapse to Opioid Use Disorder
Nanjiba Nawaz
, Michael Hester
, Christiana N. Oji-Mmuo
, Enrique Gomez
, Alicia M. Allen
Department of Pediatrics
Division of Neonatal-Perinatal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risk Factors Associated with Perinatal Relapse to Opioid Use Disorder'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Risk Factors
100%
Opioid Use Disorder
100%
United States
33%
Clinical Care
33%
Multisystem
33%
Cognitive Behavioral Therapy
33%
Opioid Dependence
33%
Social Factors
33%
Pharmacotherapy
33%
Personal Factors
33%
Personal-social
33%
Pregnant Women
33%
Methadone
33%
Buprenorphine
33%
Socio-economic Impact
33%
Human Consequences
33%
Systemic Factors
33%
Non-pharmacological
33%
Postpartum Women
33%
Opioid Agonist
33%
Neurobehavioral Functioning
33%
Societal Factors
33%
Early Postpartum
33%
Neonatal Abstinence Syndrome
33%
Opioid Epidemic
33%
Chronic Opioids
33%
Maternal Involvement
33%
Medicine and Dentistry
Opioid Abuse
100%
Clinician
40%
Prevalence
20%
Drug Therapy
20%
Counseling
20%
Methadone
20%
Buprenorphine
20%
Opioid Dependence
20%
Puerperium
20%
Opiate Agonist
20%
Cognitive Behavioral Therapy
20%
Withdrawal Syndrome
20%
Nursing and Health Professions
Diseases
100%
Counseling
20%
Prevalence
20%
Drug Therapy
20%
Syndrome
20%
Puerperium
20%
Cognitive Behavioral Therapy
20%
Opiate Addiction
20%
Buprenorphine
20%
Methadone
20%
Opiate Agonist
20%
Withdrawal Syndrome
20%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Prevalence
20%
Opiate Agonist
20%
Pharmacotherapy
20%
Syndrome
20%
Withdrawal Syndrome
20%
Opiate Addiction
20%
Methadone
20%
Buprenorphine
20%